BioVaxys Technology Corp. has closed a private placement financing, raising $1,922,984.92. The funding will support organic growth and various developmental initiatives.
Amount Raised
C$1.92 Million
Round Type
Post-IPO Equity
EtobicokeBiotechnologyHealth CareTherapeuticsDescription
BioVaxys Technology Corp. announces the closing of a non-brokered private placement financing, raising $1,922,984.92 through the issuance of 11,311,676 units at $0.17 each. The funds will be used for pipeline growth, including licensing, research collaborations, and vaccine development. This investment aims to enhance the company's capabilities in targeted immunotherapies and associated research projects.
Quick answer
BioVaxys Technology Corp. raised C$1.92 Million in a Post-IPO Equity round, dated November 19, 2025. BioVaxys Technology Corp. is based in Etobicoke, Ontario, Canada.
- How much did BioVaxys Technology Corp. raise?
- BioVaxys Technology Corp. raised C$1.92 Million in a Post-IPO Equity round on November 19, 2025.
- What does BioVaxys Technology Corp. do?
- BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF, FR:5LB), formerly BioVaxys LLC, is a British Columbia-registered clinical-stage biotechnology company dedicated to improving patient lives with novel immunotherapies..
- Where is BioVaxys Technology Corp. based and how big is it?
- BioVaxys Technology Corp. is based in Etobicoke, Ontario, Canada. Fundz records about 5 employees.
- Who are the decision-makers at BioVaxys Technology Corp?
- Fundz holds 1 contact at BioVaxys Technology Corp., including the President & Chief Operating Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as BioVaxys Technology Corp. that raised within 45 days of this round, from Fundz verified event records.
- Navega Therapeutics raised $1.3M (Seed) on January 2, 2026.
- Dermata Therapeutics raised $4.1M on December 29, 2025.
- CASI Pharmaceuticals raised $5M on December 27, 2025.
- MAIA Biotechnology raised $1.5M on December 22, 2025.
- Rezubio Pharmaceuticals raised $20M (Series A) on December 19, 2025.
- Kodiak Sciences raised $160M (Post-IPO Equity) on December 18, 2025.
Who to call at BioVaxys Technology Corp., and when
A new round usually means BioVaxys Technology Corp. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day BioVaxys Technology Corp. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioVaxys Technology Corp., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioVaxys Technology Corp.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioVaxys Technology Corp. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioVaxys Technology Corp. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.